Abbonarsi

Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial - 28/04/22

Doi : 10.1016/j.ahj.2022.02.011 
Sarah C. Couch, PhD, RD a, , Robert N. Helsley, PhD b, Francesca U. Siegel, MS c, Brian E. Saelens, PhD d, Michael Magazine, PhD e, Mark H. Eckman, MD, MS f, Suzanne Summer, PhD, RD g, Matthew Fenchel h, i, Eileen C. King, PhD h, i, Deepak L. Bhatt, MD, MPH j, Dylan L. Steen, MD, MS k
a Department of Rehabilitation, Exercise and Nutrition Sciences, University of Cincinnati, Cincinnati, OH 
b Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY 
c College of Medicine, The Ohio State University, Columbus, OH 
d Seattle Children's Research Institute and the University of Washington, Seattle, WA 
e Carl H. Lindner College of Business, University of Cincinnati, Cincinnati, OH 
f Division of General Internal Medicine and Center for Clinical Effectiveness, University of Cincinnati Medical Center, Cincinnati, OH 
g Schubert Research Clinic, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 
h Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 
i Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH 
j Brigham and Women's Hospital, Harvard Medical School, Boston, MA 
k Division of Cardiovascular Health and Disease, University of Cincinnati Medical Center, Cincinnati, OH 

Reprint requests: Sarah C. Couch, PhD, RD, Department of Rehabilitation, Exercise and Nutrition Sciences, University of Cincinnati, Cincinnati, OH 45267-0394.Department of Rehabilitation, Exercise and Nutrition SciencesUniversity of CincinnatiCincinnatiOH45267-0394

Riassunto

Purpose

The prevalence of chronic diseases is increasing largely due to suboptimal dietary habits. It is not known whether individualized, supermarket-based, nutrition education delivered by registered dietitians, utilizing the advantages of the in-store and online environments, and electronically collected purchasing data, can increase dietary quality.

Methods and results

The supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial is a randomized, controlled dietary intervention study. Adults identified from a primary care network with 1 or more risk factors were randomized at their preferred store to: (1) standard of care plus individualized, point- of-purchase nutrition education; (2) standard of care plus individualized, point- of-purchase nutrition education enhanced with online shopping technologies and training; or (3) standard of care alone. Educational sessions within each store's clinic and aisles, emphasized the dietary approaches to stop hypertension (DASH) diet. The primary assessment was an intention-to-treat comparison on the effects of the dietary interventions on mean change in DASH score (90-point range) from baseline to 3 months (post-intervention). Additional outcomes included blood pressure, lipids, weight, purchasing behavior, food literacy, and intervention feedback. Between April 2019 to February 2021, 267 participants were randomized (20 excluded due to coronavirus disease pandemic). Median age was 58 years, 69% were female, 64% had a college degree, 53% worked full-time, 64% were obese, 73% were treated with blood pressure and 42% with cholesterol medications, and most had low-to-moderate diet quality.

Conclusion

The SuperWIN trial was designed to provide a rigorous evaluation of the efficacy of 2 novel, comprehensive, supermarket-based dietary intervention programs.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : AND, DASH, PCN, POP, RD, REDCap, SuperWIN


Mappa


 Clinical trial registration: URL: NCT03895580?term=NCT03895580&draw=2&rank=1. Unique identifier: NCT03895580.


© 2022  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 248

P. 21-34 - Giugno 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale
  • Girish M Nair, David H Birnie, George A Wells, Pablo B Nery, Calum J Redpath, Jean-Francois Sarrazin, Jean-Francois Roux, Ratika Parkash, Martin Bernier, Laurence D. Sterns, Paul Novak, George Veenhuyzen, Carlos A. Morillo, Sheldon M. Singh, Marcio Sturmer, Vijay S. Chauhan, Paul Angaran, Vidal Essebag
| Articolo seguente Articolo seguente
  • Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study
  • Aubrey E. Jones, Madeleine M. McCarty, Juan P. Brito, Peter A. Noseworthy, Kerri L. Cavanaugh, Kenzie A. Cameron, Geoffrey D. Barnes, Benjamin A. Steinberg, Daniel M. Witt, George H. Crossley, Rod Passman, Preeti Kansal, Ian Hargraves, Monika Schmidt, Elizabeth Jackson, Adriana Guzman, Anthony Ariotti, Mandy L. Pershing, Jennifer Herrick, Victor M. Montori, Angela Fagerlin, Elissa M. Ozanne, STEP-UP AFIB Writing Group

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.